| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.3 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.043 | 0.1 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.28 | 0.2 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.27 | 0.2 |